malondialdehyde has been researched along with Hypertension, Renal in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (46.15) | 29.6817 |
| 2010's | 7 (53.85) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Khalili, A; Khosravi, MB; Nekooeian, AA | 1 |
| Abd-Eldayem, AM; Abdel-Zaher, AO; El-Refaiy, AEM; Farghaly, HSM | 1 |
| Demikhova, N; Prikhodko, O; Psareva, V; Sukhonos, V; Vynnychenko, L | 1 |
| Guo, WJ; Li, L; Li, RS; Qiao, X; Qiao, YF; Shao, JJ; Shao, S; Wang, LH; Zhang, Q | 1 |
| Cowley, AW; Jin, C; Polichnowski, AJ; Yang, C | 1 |
| Fakher, S; Khalili, A; Khosravi, MB; Nekooeian, AA | 1 |
| Chen, J; Li, G; Li, RJ; Qiu, J; Zhang, XN | 1 |
| Ferrebuz, A; Quiroz, Y; Rodríguez-Iturbe, B; Vanegas, V | 1 |
| Al-Shabanah, O; Khattab, MM; Mostafa, A | 1 |
| Dominic, EA; Ferrando, A; Morgan, M; Moseley, P; Osman, F; Pai, A; Pickett, G; Raj, DS; Shah, VO | 1 |
| Chowdhury, NA; Cooper, SA; Ferrario, C; Gallagher, PE; Habibi, J; Hayden, MR; Link, CD; Sowers, JR; Stump, CS; Tallant, EA; Whaley-Connell, AT; Wiedmeyer, CE | 1 |
| Chávez, M; Egido, J; Gómez-Garre, D; Gordon, K; Herrera-Acosta, J; Johnson, RJ; Largo, R; Parra, G; Pons, H; Quiroz, Y; Rincón, J; Rodríguez-Iturbe, B | 1 |
| Bonet, L; Chávez, M; Herrera-Acosta, J; Johnson, RJ; Nava, M; Pons, HA; Quiroz, Y; Rodríguez-Iturbe, B | 1 |
13 other study(ies) available for malondialdehyde and Hypertension, Renal
| Article | Year |
|---|---|
Oleuropein improves glucose tolerance and lipid profile in rats with simultaneous renovascular hypertension and type 2 diabetes.
Topics: Animals; Antioxidants; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Disease Models, Animal; Glucose Tolerance Test; Hypertension, Renal; Hypertension, Renovascular; Iridoid Glucosides; Iridoids; Lipids; Male; Malondialdehyde; Molecular Structure; Oxidative Stress; Rats; Rats, Sprague-Dawley; Streptozocin; Superoxide Dismutase | 2017 |
Protective effect of the standardized leaf extract of Ginkgo biloba (EGb761) against hypertension-induced renal injury in rats.
Topics: Animals; Antihypertensive Agents; Arterial Pressure; Cardiovascular Agents; Ginkgo biloba; Glutathione; Hypertension; Hypertension, Renal; Interleukin-1beta; Interleukin-6; Kidney; Kidney Diseases; Losartan; Male; Malondialdehyde; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Oxidative Stress; Plant Extracts; Rats; Tumor Necrosis Factor-alpha | 2018 |
[Activation of lipid peroxidation in patients with renal hypertension].
Topics: Adolescent; Adult; Female; Glomerulonephritis; Humans; Hypertension, Renal; Kidney Failure, Chronic; Lipid Peroxidation; Lipids; Male; Malondialdehyde; Middle Aged; Oxidation-Reduction | 2013 |
Melatonin attenuates hypertension-induced renal injury partially through inhibiting oxidative stress in rats.
Topics: Animals; Blood Pressure; Creatinine; Edema; Gene Expression Regulation; Heme Oxygenase-1; Hypertension, Renal; Immunohistochemistry; Inflammation; Intercellular Adhesion Molecule-1; Kidney; Kidney Diseases; Male; Malondialdehyde; Melatonin; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Oxidative Stress; Proteinuria; Rats, Wistar; RNA, Messenger; Superoxide Dismutase | 2016 |
Role of renal perfusion pressure versus angiotensin II on renal oxidative stress in angiotensin II-induced hypertensive rats.
Topics: Albuminuria; Analysis of Variance; Angiotensin II; Animals; Blood Pressure; Disease Models, Animal; Hypertension, Renal; Infusions, Intravenous; Kidney Cortex; Kidney Function Tests; Kidney Medulla; Linear Models; Male; Malondialdehyde; Oxidative Stress; Probability; Random Allocation; Rats; Rats, Sprague-Dawley; Reference Values; Renal Circulation; Superoxides; Urinalysis; Vasoconstrictor Agents | 2010 |
Simultaneous renal hypertension and type 2 diabetes exacerbate vascular endothelial dysfunction in rats.
Topics: Acetylcholine; Animals; Aorta; Blood Glucose; Blood Pressure; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Endothelium, Vascular; Glucose Tolerance Test; Hypertension, Renal; Male; Malondialdehyde; NG-Nitroarginine Methyl Ester; Nitroprusside; Phenylephrine; Rats; Rats, Sprague-Dawley; Vasoconstrictor Agents; Vasodilator Agents | 2012 |
[Pharmacodynamic study of racemic TJ0711 on renal hypertensive rats after long-term administration].
Topics: Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Endothelin-1; Female; Heart Rate; Heart Ventricles; Hydroxyproline; Hypertension, Renal; Longitudinal Studies; Male; Malondialdehyde; Organ Size; Phenoxypropanolamines; Random Allocation; Rats; Rats, Wistar; Renin | 2012 |
Hypertension in Page (cellophane-wrapped) kidney is due to interstitial nephritis.
Topics: Angiotensin II; Animals; Blood Pressure; Body Weight; Cellophane; Disease Models, Animal; Glutathione; Hypertension, Renal; Immunosuppressive Agents; Ischemia; Kidney; Kidney Function Tests; Male; Malondialdehyde; Mycophenolic Acid; Nephritis, Interstitial; Pressure; Rats; Rats, Sprague-Dawley | 2005 |
Effects of captopril on cardiac and renal damage, and metabolic alterations in the nitric oxide-deficient hypertensive rat.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Aspartate Aminotransferases; Blood Pressure; Body Weight; Captopril; Cardiomegaly; Creatinine; Enzyme Inhibitors; Glutathione; Heart Rate; Hypertension, Renal; L-Lactate Dehydrogenase; Male; Malondialdehyde; NG-Nitroarginine Methyl Ester; Nitrates; Nitric Oxide; Nitric Oxide Synthase; Nitrites; Organ Size; Peptidyl-Dipeptidase A; Rats; Rats, Wistar | 2005 |
Skeletal muscle, cytokines, and oxidative stress in end-stage renal disease.
Topics: Adult; Biopsy; Blood Proteins; Cytokines; Gene Expression; Humans; Hypertension, Renal; Interleukin-1; Interleukin-10; Interleukin-6; Kidney Failure, Chronic; Malondialdehyde; Middle Aged; Muscle, Skeletal; Oxidative Stress; Tumor Necrosis Factor-alpha | 2005 |
Oxidative stress and glomerular filtration barrier injury: role of the renin-angiotensin system in the Ren2 transgenic rat.
Topics: Albuminuria; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Animals; Animals, Genetically Modified; Blood Pressure; Disease Models, Animal; Hypertension, Renal; Kidney Glomerulus; Male; Malondialdehyde; Mice; Microscopy, Electron, Transmission; NADPH Oxidases; Neprilysin; Oxidative Stress; Peptidyl-Dipeptidase A; Podocytes; Rats; Rats, Sprague-Dawley; Renin; Renin-Angiotensin System; RNA, Messenger; Tetrazoles; Valine; Valsartan | 2006 |
Mycophenolate mofetil prevents salt-sensitive hypertension resulting from angiotensin II exposure.
Topics: Angiotensin II; Animals; Anti-Inflammatory Agents, Non-Steroidal; Blood Pressure; Body Weight; Cell Division; Creatinine; Disease Models, Animal; Fibronectins; Hypertension, Renal; Kidney; Leukocytes, Mononuclear; Lipid Peroxidation; Male; Malondialdehyde; Mycophenolic Acid; Osteopontin; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Sialoglycoproteins; Superoxides; Vasoconstrictor Agents | 2001 |
Reduction of renal immune cell infiltration results in blood pressure control in genetically hypertensive rats.
Topics: Angiotensin II; Animals; Arterioles; Blood Pressure; Catalase; Glutathione; Hypertension, Renal; Immunocompetence; Immunosuppressive Agents; Kidney; Lymphocytes; Macrophages; Male; Malondialdehyde; Mycophenolic Acid; Oxidative Stress; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Superoxides | 2002 |